{"id":813705,"date":"2025-02-17T08:34:18","date_gmt":"2025-02-17T13:34:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/"},"modified":"2025-02-17T08:34:18","modified_gmt":"2025-02-17T13:34:18","slug":"shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/","title":{"rendered":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm"},"content":{"rendered":"
\n

PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term shareholders.<\/p>\n

\n
\n Click here for additional information: <\/em>
\n <\/strong>
\n
\n
\n https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/<\/em>
\n <\/strong>
\n <\/a>\n <\/p>\n

Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cClass Period\u201d). According to the complaint, during the Class Period Integra and certain of the company\u2019s senior executive officers issued a series of materially false and misleading statements to investors concerning the company\u2019s business, operations and prospects.<\/p>\n

As detailed in the complaint, on October 9, 2018, the FDA began an inspection of the company\u2019s Boston Facility, during which it observed that Integra\u2019s quality systems and manufacturing conditions were \u201cnot in conformity with the current good manufacturing practice requirements of the Quality System Regulation.\u201d As a result, on November 2, 2018, the FDA issued a Notice of Inspectional Observations on Form 483 to put Integra on notice of those violations. After receiving the 2018 Form 483, Integra issued a series of responses purporting to address the problems identified by the FDA.<\/p>\n

On April 26, 2023, Integra revealed that it had paused production at the Boston Facility. The company also disclosed declining operating margins for the quarter and flat revenue growth projections, which it attributed to the manufacturing stoppage. As a result of these disclosures, shares of Integra\u2019s common stock declined by $4.64 per share, or 8% in value, to close at $54.20 per share on unusually heavy trading volume.<\/em><\/strong> Later that day Integra further revealed that, on March 1, 2023, the FDA had commenced another inspection of the Boston Facility and that the company expected to receive another Form 483 as a result of that inspection.<\/p>\n

Then, on May 23, 2023, the Company announced a \u201crecall\u201d of products manufactured at its Boston Facility between March 1, 2018 and May 22, 2023. Integra explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products with unsafe levels of endotoxins. Integra further disclosed that it expected to take a $22 million impairment charge in the second quarter due to the inventory write-off. Following these additional disclosures, shares of Integra\u2019s common stock fell an additional $10.24 per share, or 20% in value, to close on May 23, 2023 at $40.48 per share, again on unusually heavy trading volume.<\/em><\/strong><\/p>\n

The investigation seeks to determine whether Integra\u2019s officers and directors violated the securities laws and\/or breached their fiduciary duties in connection with the above alleged misconduct.<\/p>\n

\n
\n Integra<\/em>
\n <\/strong>
\n
\n shareholders who purchased or acquired <\/em>
\n <\/strong>
\n
\n IART shares <\/em>
\n <\/strong>
\n
\n
\n prior to <\/u>
\n <\/em>
\n <\/strong>
\n
\n
\n April 26, 2023<\/u>
\n <\/em>
\n <\/strong>
\n
\n are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 \u2013 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):<\/em>
\n <\/strong>\n <\/p>\n

\n
\n
\n https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/<\/em>
\n <\/strong>
\n <\/a>\n <\/p>\n

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com<\/a>.<\/p>\n

\n CONTACT:<\/strong>\n <\/p>\n

\n KASKELA LAW LLC<\/strong>
\n
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com<\/a>)
Adrienne Bell, Esq.
(abell@kaskelalaw.com<\/a>)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 \u2013 1740
(484) 229 \u2013 0750
www.kaskelalaw.com<\/a><\/p>\n

This notice may constitute attorney advertising in certain jurisdictions.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cClass Period\u201d). According to the complaint, during the Class Period Integra and certain of the company\u2019s senior executive officers issued a series of materially false and misleading statements to investors concerning the company\u2019s business, operations and prospects. As detailed in the complaint, on October 9, 2018, the FDA began an inspection of the … <\/p>\n

Continue reading “SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-813705","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cClass Period\u201d). According to the complaint, during the Class Period Integra and certain of the company\u2019s senior executive officers issued a series of materially false and misleading statements to investors concerning the company\u2019s business, operations and prospects. As detailed in the complaint, on October 9, 2018, the FDA began an inspection of the … Continue reading "SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-17T13:34:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm\",\"datePublished\":\"2025-02-17T13:34:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/\"},\"wordCount\":584,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/\",\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=\",\"datePublished\":\"2025-02-17T13:34:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk","og_description":"PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (\u201cIntegra\u201d) on behalf of the company\u2019s long-term shareholders. Click here for additional information: https:\/\/kaskelalaw.com\/cases\/integra-lifesciences\/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company\u2019s stock between March 11, 2019 and May 22, 2023 (the \u201cClass Period\u201d). According to the complaint, during the Class Period Integra and certain of the company\u2019s senior executive officers issued a series of materially false and misleading statements to investors concerning the company\u2019s business, operations and prospects. As detailed in the complaint, on October 9, 2018, the FDA began an inspection of the … Continue reading \"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-17T13:34:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm","datePublished":"2025-02-17T13:34:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/"},"wordCount":584,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/","name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=","datePublished":"2025-02-17T13:34:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1OTMxNCM2NzUzNTY0IzIwOTk5MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-kaskela-law-llc-announces-shareholder-investigation-of-integra-lifesciences-holdings-corp-nasdaq-iart-and-encourages-long-term-integra-investors-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Integra Investors to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=813705"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/813705\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=813705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=813705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=813705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}